BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25287161)

  • 1. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.
    Schubbert S; Cardenas A; Chen H; Garcia C; Guo W; Bradner J; Wu H
    Cancer Res; 2014 Dec; 74(23):7048-59. PubMed ID: 25287161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
    Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
    Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.
    Roderick JE; Tesell J; Shultz LD; Brehm MA; Greiner DL; Harris MH; Silverman LB; Sallan SE; Gutierrez A; Look AT; Qi J; Bradner JE; Kelliher MA
    Blood; 2014 Feb; 123(7):1040-50. PubMed ID: 24394663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
    Yuan T; Yang Y; Chen J; Li W; Li W; Zhang Q; Mi Y; Goswami RS; You JQ; Lin D; Qian MD; Calin S; Liang Y; Miranda RN; Calin GA; Zhou X; Ma L; Zweidler-McKay PA; Liu B; Weng AP; Medeiros LJ; Zhang Y; You MJ
    Leukemia; 2017 Nov; 31(11):2355-2364. PubMed ID: 28280276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of leukemia development caused by PTEN loss.
    Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1409-14. PubMed ID: 21212363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
    Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
    Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.
    Gutierrez A; Grebliunaite R; Feng H; Kozakewich E; Zhu S; Guo F; Payne E; Mansour M; Dahlberg SE; Neuberg DS; den Hertog J; Prochownik EV; Testa JR; Harris M; Kanki JP; Look AT
    J Exp Med; 2011 Aug; 208(8):1595-603. PubMed ID: 21727187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL.
    Piya S; Yang Y; Bhattacharya S; Sharma P; Ma H; Mu H; He H; Ruvolo V; Baran N; Davis RE; Jain AK; Konopleava M; Kantarjian H; Andreeff M; You MJ; Borthakur G
    Leukemia; 2022 May; 36(5):1261-1273. PubMed ID: 35173274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
    Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
    Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
    Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
    Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notching up MYC gives a LIC.
    Levens D; Aplan PD
    Cell Stem Cell; 2013 Jul; 13(1):8-9. PubMed ID: 23827704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
    Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
    Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.
    Reynolds C; Roderick JE; LaBelle JL; Bird G; Mathieu R; Bodaar K; Colon D; Pyati U; Stevenson KE; Qi J; Harris M; Silverman LB; Sallan SE; Bradner JE; Neuberg DS; Look AT; Walensky LD; Kelliher MA; Gutierrez A
    Leukemia; 2014 Sep; 28(9):1819-27. PubMed ID: 24552990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.
    Armstrong F; Brunet de la Grange P; Gerby B; Rouyez MC; Calvo J; Fontenay M; Boissel N; Dombret H; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
    Blood; 2009 Feb; 113(8):1730-40. PubMed ID: 18984862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia.
    Tamiro F; Weng AP; Giambra V
    Cancer Res; 2021 Aug; 81(16):4165-4173. PubMed ID: 33414170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
    Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
    PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.
    Gusscott S; Jenkins CE; Lam SH; Giambra V; Pollak M; Weng AP
    PLoS One; 2016; 11(8):e0161158. PubMed ID: 27532210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
    Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
    Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.